Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study

• Published in: Current controlled trials in cardiovascular medicine Vol. 23; no. 1; p. 236
• Main Authors: Trendelenburg, Valérie, Dölle-Bierke, Sabine, Unterleider, Nathalie, Alexiou, Aikaterina, Kalb, Birgit, Meixner, Lara, Heller, Stephanie, Lau, Susanne, Lee, Young- Ae, Fauchère, Florent, Braun, Julian, Babina, Magda, Altrichter, Sabine, Birkner, Till, Roll, Stephanie, Dobbertin-Welsch, Josefine, Worm, Margitta, Beyer, Kirsten
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 28.03.2022; BioMed Central; BMC
• Subjects: Adolescent; Adult; Aged; Allergens; Anaphylaxis; Arachis - adverse effects; Child; Child, Preschool; Clinical trials; Cohort analysis; Cohort Studies; Diet; Diet therapy; Drug dosages; Elimination diet; Food allergies; Food allergy in children; Food Hypersensitivity - diagnosis; Food Hypersensitivity - prevention & control; Higher threshold; Humans; Immune Tolerance; Immunology; Immunotherapy; Infant; Middle Aged; Nut Hypersensitivity - diagnosis; Nut Hypersensitivity - drug therapy; Nut Hypersensitivity - prevention & control; Nuts; Nuts - adverse effects; Observational studies; Patients; Peanut allergy; Peanuts; Protocol; Quality of life; Randomized controlled trial; Study Protocol; Tree nut allergy; Young Adult; Germany; United Kingdom > UK; Higher threshold; Tree nut allergy; Peanut allergy; Persistent food allergy; Protocol; Oral tolerance; Randomized controlled trial; Elimination diet
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-022-06149-4

Peanuts (PN) and tree nuts (TN) are among the most frequent elicitors of food allergy and can lead to life-threatening reactions. The current advice for allergic patients is to strictly avoid the offending food independently of their individual threshold level, whereas sensitized patients without allergic symptoms should frequently consume the food to avoid (re-)development of food allergy. The aim of this trial is to investigate (I) whether the consumption of low allergen amounts below the individual threshold may support natural tolerance development and (II) to what extent regular allergen consumption in sensitized but tolerant subjects prevents the (re-)development of PN or TN allergy. The TINA trial consisting of (part I) a randomized, controlled, open, parallel group, single-center, superiority trial (RCT), and (part II) a prospective observational exploratory cohort study. Children and adults (age 1-67 years) with suspected or known primary PN and/or TN allergy will undergo an oral food challenge (OFC) to determine their clinical reactivity and individual threshold. In the RCT, 120 PN or TN allergic patients who tolerate ≥100 mg of food protein will be randomized (1:1 ratio) to consumption of products with low amounts of PN or TN on a regular basis or strict avoidance for 1 year. The consumption group will start with 1/100 of their individual threshold, increasing the protein amount to 1/50 and 1/10 after 4 and 8 months, respectively. The primary endpoint is the clinical tolerance to PN or TN after 1 year assessed by OFC. In the cohort study, 120 subjects sensitized to PN and/or TN but tolerant are advised to regularly consume the food and observed for 1 year. The primary endpoint is the maintenance of clinical tolerance to PN and/or TN after 1 year assessed by challenging with the former tolerated cumulative dose. This clinical trial will help to determine the impact of allergen consumption versus avoidance on natural tolerance development and whether the current dietary advice for PN or TN allergic patients with higher threshold levels is still valid. German Clinical Trials Register; ID: DRKS00016764 (RCT), DRKS00020467 (cohort study). Registered on 15 January 2020, http://www.drks.de .